Proteoglycans in Mouse Lymphoma Cells and Metastasis
Author Information
Author(s): R. Schwartz-Albiez, I. Steffen, A. Lison, N. Giittler, V. Schirrmacher, R. Keller
Primary Institution: German Cancer Research Center, Institute of Immunology and Genetics
Hypothesis
The study investigates the expression and secretion of glycosaminoglycans (GAGs) in mouse lymphoma cells with varying metastatic capacities.
Conclusion
Highly metastatic ESb cells secrete significantly more glycosaminoglycans than low metastatic Eb and ESb-MP cells.
Supporting Evidence
- ESb cells secreted more GAGs than Eb and ESb-MP cells.
- Eb cells produced both chondroitin/dermatan sulphate and heparan sulphate, while ESb and ESb-MP cells only produced chondroitin/dermatan sulphate.
- The GAGs from ESb cells had a higher portion of dermatan sulphate compared to ESb cells.
Takeaway
This study looks at how certain substances made by cancer cells might help them spread more easily in the body. It finds that more of these substances are made by the more aggressive cancer cells.
Methodology
The study analyzed the expression and secretion of GAGs in three mouse lymphoma cell lines using various biochemical techniques.
Want to read the original?
Access the complete publication on the publisher's website